Is there a thyroid ultrasound feature not currently included in risk stratification systems? A multi-institutional report discovers a novel pattern of peripheral punctate echogenic foci and examines its association with papillary thyroid carcinoma. ow.ly/vIaj50ZVwnt

What options remain when advanced thyroid cancer progresses despite multiple prior therapies? Investigators from @MSKCancerCenter evaluated the activity of pemetrexed-based treatment in RAI-refractory differentiated and anaplastic thyroid cancer. ow.ly/SY3r50ZVwqb

Can we better predict outcomes for thyroid cancer patients with brain metastases? A new @thyroidjournal international multicenter study developed a disease-specific prognostic score and identified key factors linked to survival. ow.ly/w8QA50ZVwqj #ThyroidJournal

When does thyroid RFA become economically comparable to surgery? This one-year micro-costing analysis from @UofT examined the drivers of cost for RFA and hemithyroidectomy and identified key thresholds that could shift the balance. ow.ly/9jZG50ZVwpZ #ThyroidJournal

Do patients with Graves' disease and low baseline TRAb really need 12–18 months of antithyroid drugs? In this new @thyroidjournal study, ATD courses <12 months had similar relapse rates, raising the possibility of TRAb-guided shorter treatment. ow.ly/kj3A50ZVwpK

The October issue of @thyroidjournal is now available online! ow.ly/4iYn50ZTVYc #AmericanThyroidAssociation #ATAthyroid2026 #ThyroidJournal #endotwitter #medtwitter

Who develops goiter in the U.S.? A new multi-institutional study estimates 1.3–2.5% of working-age adults have goiter, with rates varying by age, sex, and region—raising questions about environmental and geographic influences. ow.ly/PYy250ZIP3v #ThyroidJournal #medtwitter

Has the treatment of pediatric hyperthyroidism changed over time? A new @thyroidjournal study from @TelAvivUni found a shift toward longer medical therapy and fewer definitive treatments—but with higher relapse rates, highlighting important tradeoffs. ow.ly/bwBB50ZIONh

Does levothyroxine dose affect how often treatment falls out of range? A real-world study by @mettleson and team found patients taking higher doses were more likely to have abnormal TSH levels, suggesting they may benefit from closer follow-up. ow.ly/MIy250ZIOIG

What role do thyroid hormones play outside the thyroid? check out this new @thyroidjournal study from Italy that suggests they may influence polycystic kidney disease progression and represent a potential therapeutic target. ow.ly/laLE50ZIOwq #ThyroidJournal

Could a once-weekly subcutaneous levothyroxine injection replace daily pills? A Phase 2 study by @Bianco_Lab and @XerisPharma found it was well tolerated, achieved thyroid hormone targets, and was preferred by many participants. ow.ly/sKwF50ZIOrM #ThyroidJournal

Should thyroid function be optimized before major cardiac surgery? A new @thyroidjournal study suggests patients with hypothyroidism face higher risks of postoperative complications and long-term cardiovascular events after CABG. ow.ly/kycI50ZIOny #ThyroidJournal

Could "borderline" thyroglobulin antibodies still matter after thyroid cancer treatment? A new @thyroidjournal study suggests detectable TgAb—even below the traditional positive cutoff—may identify patients at higher risk of recurrence. ow.ly/ygqU50ZIOgx #ThyroidJournal

Should long-term TSH suppression be indefinite in postmenopausal women with DTC? A new study highlights potential effects on bone/muscle/CVS/QOL, especially in low-risk/disease-free women, reinforcing the importance of avoiding unnecessary suppression. ow.ly/qJs450ZIO2j

The September issue of @thyroidjournal is now available online! ow.ly/nGqH50ZHEue #AmericanThyroidAssociation #ATAthyroid2026 #ThyroidJournal #endotwitter #medtwitter

Can clinical decision tools improve care for patients with indeterminate thyroid nodules? A new @thyroidjournal review examines the current evidence, their strengths and limitations, and why clinical judgment remains essential. ow.ly/7uHm50ZvnEF @AmThyroidAssn

Could an elevated TSH be misleading? A new @thyroidjournal study from Japan examines the prevalence and clinical features of macro-TSH, an uncommon cause of apparent subclinical hypothyroidism that can complicate diagnosis and management. ow.ly/Bn8x50ZvnCX @AmThyroidAssn

Can low-risk thyroid cancer survivors be safely followed in primary care? Check out this new @thyroidjournal prospective study to see who could potentially be followed with less intensive surveillance. ow.ly/QVUC50ZvnBB @AmThyroidAssn #ThyroidJournal

What predicts poor emotional functioning after thyroid cancer treatment? A @thyroidjournal study identified exhaustion, head and neck discomfort, and body image concerns as modifiable risk factors—potential targets for earlier supportive care. ow.ly/9p5i50ZvnB1

Can AI eliminate the need for CT in thyroid SPECT? A prospective multicenter Korean trial found CT-free AI SPECT matched SPECT/CT for diagnosing thyrotoxicosis while reducing radiation by one-third and analysis time from 40 to 4 minutes. ow.ly/MMY050ZvnAK